ENLV icon

Enlivex Therapeutics
ENLV

Overview Fund Activity

24 hedge funds and large institutions have $3.99M invested in Enlivex Therapeutics in 2024 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 4 closing their positions.

Holders
24
Holders Change
+5
Holders Change %
+26.32%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
8
Reduced
3
Closed
4
Calls
$15K
Puts
$11K
Net Calls
+$4K
Net Calls Change
-$42K

Top Buyers

1
Millennium Management
1
Millennium Management
New York
$742K
2
Renaissance Technologies
2
Renaissance Technologies
New York
$186K
3
AC
3
Armistice Capital
New York
$2.58M
4
Morgan Stanley
4
Morgan Stanley
New York
$315K
5
TSS
5
Two Sigma Securities
New York
$26.2K

Top Sellers

1
XT
1
XTX Topco
Cayman Islands
$0
2
Goldman Sachs
2
Goldman Sachs
New York
$0
3
Group One Trading
3
Group One Trading
Illinois
$0
4
UBS Group
4
UBS Group
Switzerland
$19
5
SIC
5
Sigma Investment Counselors
Michigan
$32.8K
Name Holding Trade Value Shares
Change 		Shares
Change %
Goldman Sachs
26
Goldman Sachs
New York
– -$23.4K -13,935 Closed
Group One Trading
27
Group One Trading
Illinois
– -$9.63K -5,730 Closed
GRP
28
Global Retirement Partners
California
– -$18 -11 Closed
1
2